Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

1(25%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

25%

Ph phase_1

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

3(75.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Detailed Status

Completed3

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 13 (75.0%)

N/A1 (25.0%)

Trials by Status

recruiting125%

completed375%

Recent Activity

1 active trials

Showing 4 of 4

recruitingphase_1

Phase 1 Study of Intravaginal KB15A

NCT07222020

completednot_applicable

The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy

NCT02602366

completedphase_1

Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms

NCT02569697

completedphase_1

A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04

NCT01989663

Clinical Trials (4)

Showing 4 of 4 trials

NCT07222020Phase 1

Phase 1 Study of Intravaginal KB15A

Recruiting

NCT02602366Not Applicable

The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy

Completed

NCT02569697Phase 1

Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms

Completed

NCT01989663Phase 1

A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4